NFKB1 and neoplasm: In this study, we provide evidence that tumor-induced systemic inflammation activates NF-κB signaling in the hypothalamus, leading to upregulation of key pro-inflammatory genes (IL-1β, TNF-α and IL-6) within the CNS.